Xilio Therapeutics, Inc. XLO Q3 2025 earnings

FAQ

When did Xilio Therapeutics, Inc. report Q3 2025 earnings?

Xilio Therapeutics, Inc. (XLO) reported Q3 2025 earnings on November 13, 2025 before market open.

What were Xilio Therapeutics, Inc.'s Q3 2025 revenue and EPS?

Xilio Therapeutics, Inc. reported revenue of $19.1M and eps of $-0.03 for Q3 2025.

Did Xilio Therapeutics, Inc. beat estimates in Q3 2025?

Revenue beat the consensus estimate of $18.6M by $431.0K. EPS beat the consensus estimate of $-0.45 by $0.42.

How did Xilio Therapeutics, Inc.'s Q3 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 742.5% from $2.3M a year earlier and eps grew 86.4% from $-0.22.

Where can I find Xilio Therapeutics, Inc.'s Q3 2025 SEC filings?

You can read the 8-K earnings release (0001193125-25-278835) and the 10-Q periodic report (0001193125-25-278837) directly on SEC EDGAR. The filing index links above go to sec.gov.